None listed
Conditions
Interventions
Experimental group (Bupivacaine 2.85 mg):Administer 2.85 mg of Bupivacaine during subarachnoid block.
Control group (Bupivacaine 5.1 mg):Administer 5.1 mg of Bupivacaine during subarachnoid block.
Sponsors
The Second Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for proctological surgery; 2. ASA classification I to III; 3. Aged 18 to 75 years, any gender, with a body mass index of 18 to 28 kg/m2; 4. Patients who choose intrathecal combined blockade as the anesthesia method;
Exclusion criteria
Exclusion criteria: 1. The patient and family do not agree to the implementation of this anesthesia method; 2. The patient has contraindications for epidural anesthesia, such as coagulation disorders, infections at the puncture site, and central nervous system lesions; 3. Patients who are unable to communicate normally, such as those who are deaf or aphasic; 4. Patients with mental health issues who cannot cooperate with the anesthesiologist to complete the relevant anesthesia procedures; 5. The patient has participated in other drug clinical studies within the past 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of nausea and vomiting during anesthesia and within 24 hours post-surgery.;Incidence of hypotension during anesthesia and the first 24 hours post-operation.;The incidence of urinary retention during anesthesia and within 24 hours post-operation.; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR15 scale scoring;First time out of bed;Patient Satisfaction; | — |
Countries
China
Contacts
Public ContactDuan Guangyou
The Second Affiliated Hospital of Chongqing Medical University
Outcome results
None listed